•
Jun 30, 2016

Corcept Therapeutics Q2 2016 Earnings Report

Total Revenue
$19.7M
Previous year: $12M
+65.0%
EPS
$0.03
Previous year: -$0.02
-250.0%
Gross Profit
$19.3M
Cash and Equivalents
$41.8M
Total Assets
$56.8M

Corcept Therapeutics

Corcept Therapeutics